130 related articles for article (PubMed ID: 35246318)
1. Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
Paszek E; Pociask E; Ząbczyk M; Piórkowski A; Butenas S; Legutko J; Undas A
Atherosclerosis; 2022 Apr; 346():124-132. PubMed ID: 35246318
[TBL] [Abstract][Full Text] [Related]
2. Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.
Paszek E; Pociask E; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2022 Dec; 52(12):e13857. PubMed ID: 35996895
[TBL] [Abstract][Full Text] [Related]
3. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
[TBL] [Abstract][Full Text] [Related]
4. Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy.
Zabczyk M; Butenas S; Palka I; Nessler J; Undas A
Pol Arch Med Wewn; 2010 Sep; 120(9):334-40. PubMed ID: 20864906
[TBL] [Abstract][Full Text] [Related]
5. Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.
Undas A; Slowik A; Gissel M; Mann KG; Butenas S
Thromb Res; 2011 Nov; 128(5):e62-6. PubMed ID: 21820158
[TBL] [Abstract][Full Text] [Related]
6. Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation.
Jankowski M; Undas A; Kaczmarek P; Butenas S
Thromb Res; 2011 Mar; 127(3):242-6. PubMed ID: 21236471
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients.
Ząbczyk M; Butenas S; Plicner D; Fijorek K; Sadowski J; Undas A
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):189-94. PubMed ID: 22343680
[TBL] [Abstract][Full Text] [Related]
8. Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events.
Undas A; Slowik A; Gissel M; Mann KG; Butenas S
Eur J Clin Invest; 2012 Feb; 42(2):123-9. PubMed ID: 21707613
[TBL] [Abstract][Full Text] [Related]
9. Factor XIa and tissue factor activity in patients with coronary artery disease.
Butenas S; Undas A; Gissel MT; Szuldrzynski K; Zmudka K; Mann KG
Thromb Haemost; 2008 Jan; 99(1):142-9. PubMed ID: 18217146
[TBL] [Abstract][Full Text] [Related]
10. Active FXI Can Independently Predict Ischemic Stroke in Anticoagulated Atrial Fibrillation Patients: A Cohort Study.
Ząbczyk MT; Hanarz M; Malinowski KP; Pociask E; Butenas S; Gajos G; Undas A
Thromb Haemost; 2022 Aug; 122(8):1397-1406. PubMed ID: 35158400
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive.
Waters EK; Hilden I; Sørensen BB; Ezban M; Holm PK
J Thromb Haemost; 2015 Nov; 13(11):2041-52. PubMed ID: 26340413
[TBL] [Abstract][Full Text] [Related]
12. Activation of the contact system in patients with a first acute myocardial infarction.
Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H
Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study.
Paszek E; Polak M; Bryk-Wiązania AH; Konieczyńska M; Undas A
Cardiovasc Diabetol; 2023 Jul; 22(1):182. PubMed ID: 37460982
[TBL] [Abstract][Full Text] [Related]
14. Predictive value for increased activated factor XI activity in acute venous thromboembolism.
Nagy M; Robles AP; Visser M; Koeck T; Ten Cate V; Ten Cate-Hoek AJ; Schwers S; Heitmeier S; Ten Cate H; Wild PS; Spronk HMH
J Thromb Haemost; 2023 Jun; 21(6):1610-1622. PubMed ID: 37003466
[TBL] [Abstract][Full Text] [Related]
15. Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.
Luszczak J; Undas A; Gissel M; Olszowska M; Butenas S
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):473-9. PubMed ID: 21519234
[TBL] [Abstract][Full Text] [Related]
16. Effect of factor XI inhibition on tumor cell-induced coagulation activation.
Mäder J; Rolling CC; Voigtländer M; Schulenkorf A; Lehr C; Regenhardt J; Bokemeyer C; Beckmann L; Langer F
J Thromb Haemost; 2024 Jan; 22(1):199-212. PubMed ID: 37751848
[TBL] [Abstract][Full Text] [Related]
17. Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke.
Kusak P; Czarnecka D; Gissel M; Plens K; Butenas S; Undas A
Arch Med Sci; 2016 Oct; 12(5):1000-1007. PubMed ID: 27695490
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic Risk of Imaging-Confirmed Coronary Artery Disease Without Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation.
Cho MS; Lee K; Choi KJ; Lee JB; Do U; Kim YN; Kim J; Nam GB; Kim YH
Am J Cardiol; 2019 Apr; 123(8):1287-1292. PubMed ID: 30709601
[TBL] [Abstract][Full Text] [Related]
19. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.
Goldman S; Prior SM; Bembenek JP; Niewada M; Broniatowska E; Członkowska A; Butenas S; Undas A
J Thromb Thrombolysis; 2017 Oct; 44(3):362-370. PubMed ID: 28879581
[TBL] [Abstract][Full Text] [Related]
20. Comparative Thrombin Generation in Animal Plasma: Sensitivity to Human Factor XIa and Tissue Factor.
Liang Y; Tarandovskiy I; Surov SS; Ovanesov MV
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
